Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions

---

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on menopausal hormone therapy for the primary prevention of chronic conditions.

---

Current Recommendations

Release Date: October 2012

• The USPSTF recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women.
  Grade: D Recommendation.
• The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy.
  Grade: D Recommendation.

Supporting Documents

Supporting Document	Related Items
Recommendation Statement (PDF File, 169 KB; PDF Help)	Clinical Summary (PDF File, 57 KB; PDF Help)
	Consumer Fact Sheet (PDF File, 114 KB; PDF Help)
Evidence Report (PDF File, 164 KB; PDF Help)	Evidence Synthesis (PDF File, 1 MB; PDF Help)

Current as of January 2013

---

Internet Citation:

Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions, Topic Page. January 2013. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspspmho.htm

---